MMBG Investment Advisors’s AstraZeneca AZN Stock Holding History

MMBG Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.56M	Buy	13,514 +2,535	+23%	+$477K	0.2%	68
2026 Q1	$2.17M	Sell	10,979 -3,211	-23%	-$619K	0.2%	68
2025 Q4	$2.61M	Buy	14,190 +6,430	+83%	+$1.13M	0.22%	59
2025 Q3	$1.19M	Buy	7,760 +820	+12%	+$124K	0.11%	96
2025 Q2	$970K	Hold	6,940	–	–	0.1%	96
2025 Q1	$1.02M	Buy	6,940 +3,210	+86%	+$464K	0.12%	87
2024 Q4	$489K	Buy	3,730 +825	+28%	+$116K	0.05%	123
2024 Q3	$453K	Buy	+2,905	New	+$469K	0.05%	126

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

MMBG Investment Advisors's AZN Position: Q2 2026 in Review

MMBG Investment Advisors increased its AstraZeneca (AZN) stake by 23% in Q2 2026, buying an estimated $477K and bringing the position to 13,514 shares worth $2.56M. The position accounts for 0.2% of the portfolio, ranked #68.

MMBG Investment Advisors first reported a position in AZN in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.61M in Q4 2025. 1,053 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

MMBG Investment Advisors held 13,514 shares of AstraZeneca worth $2.56M as of Q2 2026.
MMBG Investment Advisors bought 2,535 AstraZeneca shares in Q2 2026, an estimated $477K.
AstraZeneca made up 0.2% of MMBG Investment Advisors's portfolio in Q2 2026, its #68 holding.
MMBG Investment Advisors first reported a position in AstraZeneca in Q3 2024 and has held it in 8 quarters since.
MMBG Investment Advisors's AstraZeneca position peaked at $2.61M in Q4 2025.
1,053 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on MMBG Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.